Skip to content

Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01804751
Enrollment
Unknown
Registered
2013-03-05
Start date
2016-01-31
Completion date
Unknown
Last updated
2015-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Brief summary

The purpose of this study is to build a model for the prediction of adverse perinatal outcome for preeclampsia in china

Interventions

None listed

Sponsors

Sichuan Academy of Medical Sciences
CollaboratorOTHER
Guang'an people's hospital of Sichuan province
CollaboratorOTHER
The First People's Hospital of Neijiang
CollaboratorOTHER
Suining Central Hospital
CollaboratorOTHER
Sichuan Provincial Maternal and Child Health Care Hospital
CollaboratorUNKNOWN
Chengdu Women's and Children's Central Hospital
CollaboratorOTHER
Luzhou Medical College
CollaboratorOTHER
pengzhou shi fuyou baojianyuan
CollaboratorUNKNOWN
Nanchong Central Hospital
CollaboratorOTHER_GOV
West China Second University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* admitted with preeclampsia or had developed preeclampsia after admission

Exclusion criteria

* admitted in spontaneous labour or had achieved any component of the maternal outcome before either fulfilling eligibility criteria or collection of predictor data

Design outcomes

Primary

MeasureTime frame
maternal mortalitywithin 48h of eligibility

Secondary

MeasureTime frame
serious central nervous system morbiditywithin 48h of eligibility
serious cardiorespiratory morbiditywithin 48h of eligibility
serious hepatic morbidity.within 48h of eligibility
serious renal morbiditywithin 48h of eligibility
serious haematological morbiditywithin 48h of eligibility

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026